跳至主要内容
临床试验/CTRI/2022/08/044996
CTRI/2022/08/044996尚未招募未知

COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENion to Reduce Cardiovascular Events COMBINE-INTERVENE trial. Acronym COMBINE-INTERVENE - COMBINE-INTERVENE

Diagram BV0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients undergoing PCI with any clinical presentation
  • 2. At least 2 de novo target lesions located in 2 different native coronary arteries feasible for treatment
  • 3. Diameter Stenosis >50%
  • 4. The de novo lesion located in native (non-grafted) vessel
  • 5. TIMI 3 flow in all vessels (except culprit lesions in patietns with myocardial infarction)

排除标准

  • 1. Multi-vessel disease requiring CABG treatment
  • 2. Lesion in a grafted segment or vein graft
  • 3. In-stent restenosis
  • 4. Left main trifurcation
  • 5. Left main lesion stand-alone
  • 6. Severe tortuous lesions such that FFR and OCT judged impossible/dangerous
  • 7. Chronic total occlusion

研究者

发起方
Diagram BV

相似试验

Evaluation of the present pressure criteria for a... | 临床试验